Home / Fact sheets / Denmark / Cervical quantitative data
Country fact sheet: Denmark (Index year: )
Age group | 20-24 | 25-29 | 30-34 | 35-39 | 40-44 | 45-49 | 50-54 | 55-59 | 60-64 | 65-69 | 70-74 | 75-79 | Age unknown | Total |
Interval | ||||||||||||||
Screening interval (months) | 36 | 36 | 36 | 36 | 36 | 36 | 36 | 36 | 60 | 0 | 0 | 0 | 0 | |
Population (personally invited) | ||||||||||||||
Target population | 176575 | 159475 | 163374 | 185843 | 192693 | 211165 | 186036 | 176918 | 172565 | 0 | 0 | 0 | 0 | 1 624 644 |
Annual target population | 58 858 | 53 158 | 54 458 | 61 947 | 64 231 | 70 388 | 62 012 | 58 972 | 34 513 | 0 | 0 | 0 | 0 | 518 537 |
Women invited | 33341 | 40809 | 39806 | 45953 | 49300 | 52794 | 26271 | 35407 | 37603 | 0 | 0 | 0 | 0 | 361 284 |
Invitation coverage (%) | 56.6 | 76.8 | 73.1 | 74.2 | 76.8 | 75.0 | 42.4 | 60.0 | 109.0 | 0.0 | 0.0 | 0.0 | 0.0 | 69.7 |
Examinations | ||||||||||||||
Women screened | 18 194 | 21 791 | 25 789 | 31 546 | 34 503 | 37 201 | 16 936 | 22 998 | 23 716 | 0 | 0 | 0 | 0 | 232 674 |
Examination coverage rate (%) | 54.6 | 53.4 | 64.8 | 68.6 | 70.0 | 70.5 | 64.5 | 65.0 | 63.1 | 0.0 | 0.0 | 0.0 | 0.0 | 64.4 |
Result (A subset of tests) | ||||||||||||||
Subset women screened | 6 645 | 56 083 | 55 485 | 58 423 | 58 109 | 58 684 | 37 221 | 36 874 | 33 297 | 1 740 | 0 | 0 | 0 | 402 561 |
Positive | 675 | 3 257 | 2 644 | 2 116 | 1 805 | 1 380 | 778 | 579 | 584 | 38 | 0 | 0 | 0 | 13 856 |
Negative | 5 970 | 52 826 | 52 841 | 56 307 | 56 304 | 57 304 | 36 443 | 36 295 | 32 713 | 1 702 | 0 | 0 | 0 | 388 705 |
Unknown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Referral for further assessment (%) | 10.2 | 5.8 | 4.8 | 3.6 | 3.1 | 2.4 | 2.1 | 1.6 | 1.8 | 2.2 | 0.0 | 0.0 | 0.0 | 3.4 |
Further assessment (all positive) | ||||||||||||||
Done | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Not done | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unknown | 675 | 3 257 | 2 644 | 2 116 | 1 805 | 1 380 | 778 | 579 | 584 | 38 | 0 | 0 | 0 | 13 856 |
Further assessment participation rate (%) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Outcome (CIN 1, CIN 2 and CIN 3 separetely) | ||||||||||||||
No biopsy performed, no CIN nor ca detected | 499 | 1 000 | 964 | 915 | 855 | 800 | 531 | 437 | 472 | 0 | 0 | 0 | 0 | 6 473 |
No biopsy performed, treated on the basis of colpo diagnosis of CIN (see and treat) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unsatisfactory histology | 2 | 4 | 3 | 1 | 1 | 0 | 2 | 6 | 9 | 0 | 0 | 0 | 0 | 28 |
Carcinoma | 0 | 6 | 9 | 18 | 22 | 13 | 4 | 4 | 5 | 0 | 0 | 0 | 0 | 81 |
CIN3 / Adenocarcinoma in situ (CGIN) | 428 | 880 | 733 | 546 | 374 | 203 | 63 | 36 | 46 | 0 | 0 | 0 | 0 | 3 309 |
CIN2 | 253 | 419 | 372 | 286 | 188 | 134 | 33 | 41 | 20 | 0 | 0 | 0 | 0 | 1 746 |
CIN1 | 336 | 478 | 395 | 332 | 306 | 214 | 89 | 57 | 39 | 0 | 0 | 0 | 0 | 2 246 |
Other histology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unknown | -1 518 | -2 787 | -2 476 | -2 098 | -1 746 | -1 364 | -722 | -581 | -591 | 0 | 0 | 0 | 0 | -13 883 |